# Immunization With Autologous Dendritic Cells and Tumor Lysates in Melanoma Patients

> **NCT06152367** · PHASE1,PHASE2 · COMPLETED · sponsor: **University of Chile** · enrollment: 90 (actual)

## Conditions studied

- Stage III Malignant Melanoma of Skin AJCC V6
- Stage IV Malignant Melanoma of Skin

## Interventions

- **BIOLOGICAL:** TAPCells vaccine

## Key facts

- **NCT ID:** NCT06152367
- **Lead sponsor:** University of Chile
- **Sponsor class:** OTHER
- **Phase:** PHASE1,PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2001-01-30
- **Primary completion:** 2004-10-09
- **Final completion:** 2004-10-09
- **Target enrollment:** 90 (ACTUAL)
- **Last updated:** 2023-11-30


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT06152367

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT06152367, "Immunization With Autologous Dendritic Cells and Tumor Lysates in Melanoma Patients". Retrieved via AI Analytics 2026-07-02 from https://api.ai-analytics.org/clinical/NCT06152367. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*